Literature DB >> 25135185

Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population.

Kei Asayama1, Lutgarde Thijs1, Yan Li1, Yu-Mei Gu1, Azusa Hara1, Yan-Ping Liu1, Zhenyu Zhang1, Fang-Fei Wei1, Inés Lujambio1, Luis J Mena1, José Boggia1, Tine W Hansen1, Kristina Björklund-Bodegård1, Kyoko Nomura1, Takayoshi Ohkubo1, Jørgen Jeppesen1, Christian Torp-Pedersen1, Eamon Dolan1, Katarzyna Stolarz-Skrzypek1, Sofia Malyutina1, Edoardo Casiglia1, Yuri Nikitin1, Lars Lind1, Leonella Luzardo1, Kalina Kawecka-Jaszcz1, Edgardo Sandoya1, Jan Filipovský1, Gladys E Maestre1, Jiguang Wang1, Yutaka Imai1, Stanley S Franklin1, Eoin O'Brien1, Jan A Staessen1.   

Abstract

Outcome-driven recommendations about time intervals during which ambulatory blood pressure should be measured to diagnose white-coat or masked hypertension are lacking. We cross-classified 8237 untreated participants (mean age, 50.7 years; 48.4% women) enrolled in 12 population studies, using ≥140/≥90, ≥130/≥80, ≥135/≥85, and ≥120/≥70 mm Hg as hypertension thresholds for conventional, 24-hour, daytime, and nighttime blood pressure. White-coat hypertension was hypertension on conventional measurement with ambulatory normotension, the opposite condition being masked hypertension. Intervals used for classification of participants were daytime, nighttime, and 24 hours, first considered separately, and next combined as 24 hours plus daytime or plus nighttime, or plus both. Depending on time intervals chosen, white-coat and masked hypertension frequencies ranged from 6.3% to 12.5% and from 9.7% to 19.6%, respectively. During 91 046 person-years, 729 participants experienced a cardiovascular event. In multivariable analyses with normotension during all intervals of the day as reference, hazard ratios associated with white-coat hypertension progressively weakened considering daytime only (1.38; P=0.033), nighttime only (1.43; P=0.0074), 24 hours only (1.21; P=0.20), 24 hours plus daytime (1.24; P=0.18), 24 hours plus nighttime (1.15; P=0.39), and 24 hours plus daytime and nighttime (1.16; P=0.41). The hazard ratios comparing masked hypertension with normotension were all significant (P<0.0001), ranging from 1.76 to 2.03. In conclusion, identification of truly low-risk white-coat hypertension requires setting thresholds simultaneously to 24 hours, daytime, and nighttime blood pressure. Although any time interval suffices to diagnose masked hypertension, as proposed in current guidelines, full 24-hour recordings remain standard in clinical practice.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  ambulatory blood pressure monitoring; cardiovascular risk; masked hypertension; population science; white-coat hypertension

Mesh:

Year:  2014        PMID: 25135185      PMCID: PMC4420482          DOI: 10.1161/HYPERTENSIONAHA.114.03614

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  34 in total

1.  Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study.

Authors:  Marjo-Riitta A Hänninen; Teemu J Niiranen; Pauli J Puukka; Jouni Johansson; Antti M Jula
Journal:  J Hypertens       Date:  2012-04       Impact factor: 4.844

2.  Short- and long-term incidence of stroke in white-coat hypertension.

Authors:  Paolo Verdecchia; Gian Paolo Reboldi; Fabio Angeli; Giuseppe Schillaci; Joseph E Schwartz; Thomas G Pickering; Yutaka Imai; Takayoshi Ohkubo; Kazuomi Kario
Journal:  Hypertension       Date:  2004-12-13       Impact factor: 10.190

3.  Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men.

Authors:  Kristina Björklund; Lars Lind; Björn Zethelius; Bertil Andrén; Hans Lithell
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

4.  Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension.

Authors:  K Kario; K Shimada; J E Schwartz; T Matsuo; S Hoshide; T G Pickering
Journal:  J Am Coll Cardiol       Date:  2001-07       Impact factor: 24.094

5.  Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.

Authors:  Takayoshi Ohkubo; Masahiro Kikuya; Hirohito Metoki; Kei Asayama; Taku Obara; Junichiro Hashimoto; Kazuhito Totsune; Haruhisa Hoshi; Hiroshi Satoh; Yutaka Imai
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

6.  Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk.

Authors:  Masahiro Kikuya; Tine W Hansen; Lutgarde Thijs; Kristina Björklund-Bodegård; Tatiana Kuznetsova; Takayoshi Ohkubo; Tom Richart; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jan A Staessen
Journal:  Circulation       Date:  2007-04-09       Impact factor: 29.690

7.  Blood pressure load does not add to ambulatory blood pressure level for cardiovascular risk stratification.

Authors:  Yan Li; Lutgarde Thijs; José Boggia; Kei Asayama; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Jan Filipovsky; Yutaka Imai; Hans Ibsen; Eoin O'Brien; Jiguang Wang; Jan A Staessen
Journal:  Hypertension       Date:  2014-02-17       Impact factor: 10.190

8.  The Maracaibo Aging Study: population and methodological issues.

Authors:  Gladys E Maestre; Gloria Pino-Ramírez; Aldrin E Molero; Eglé R Silva; Raquel Zambrano; Luis Falque; María P Gamero; Tulio A Sulbarán
Journal:  Neuroepidemiology       Date:  2002 Jul-Aug       Impact factor: 3.282

9.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

10.  Masked hypertension in diabetes mellitus: treatment implications for clinical practice.

Authors:  Stanley S Franklin; Lutgarde Thijs; Yan Li; Tine W Hansen; José Boggia; Yanping Liu; Kei Asayama; Kristina Björklund-Bodegård; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Jan Filipovsky; Yutaka Imai; Jiguang Wang; Hans Ibsen; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2013-03-11       Impact factor: 10.190

View more
  40 in total

1.  Masked Hypertension and Cardiovascular Disease Events in a Prospective Cohort of Blacks: The Jackson Heart Study.

Authors:  John N Booth; Keith M Diaz; Samantha R Seals; Mario Sims; Joseph Ravenell; Paul Muntner; Daichi Shimbo
Journal:  Hypertension       Date:  2016-06-27       Impact factor: 10.190

2.  Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain.

Authors:  Teresa Gijón-Conde; Auxiliadora Graciani; Esther López-García; Pilar Guallar-Castillón; Esther García-Esquinas; Fernando Rodríguez-Artalejo; José R Banegas
Journal:  Hypertens Res       Date:  2017-02-09       Impact factor: 3.872

3.  Prognostic Value of Masked Uncontrolled Hypertension.

Authors:  Sante D Pierdomenico; Anna M Pierdomenico; Francesca Coccina; Denis L Clement; Marc L De Buyzere; Dirk A De Bacquer; Iddo Z Ben-Dov; Wanpen Vongpatanasin; José R Banegas; Luis M Ruilope; Lutgarde Thijs; Jan A Staessen
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

Review 4.  Observational study and participant-level meta-analysis on antihypertensive drug treatment-related cardiovascular risk.

Authors:  Kei Asayama
Journal:  Hypertens Res       Date:  2017-04-27       Impact factor: 3.872

Review 5.  Masked Hypertension: Whom and How to Screen?

Authors:  D Edmund Anstey; Nathalie Moise; Ian Kronish; Marwah Abdalla
Journal:  Curr Hypertens Rep       Date:  2019-04-04       Impact factor: 5.369

6.  Masked hypertension.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-12

Review 7.  Ambulatory Blood Pressure Monitoring: A Complementary Strategy for Hypertension Diagnosis and Management in Low-Income and Middle-Income Countries.

Authors:  Marwah Abdalla
Journal:  Cardiol Clin       Date:  2017-02       Impact factor: 2.213

8.  Cardiovascular Risk Factors and Masked Hypertension: The Jackson Heart Study.

Authors:  Samantha G Bromfield; Daichi Shimbo; John N Booth; Adolfo Correa; Gbenga Ogedegbe; April P Carson; Paul Muntner
Journal:  Hypertension       Date:  2016-10-24       Impact factor: 10.190

Review 9.  Clinical studies on pharmacological treatment of hypertension in Japan.

Authors:  Kazuomi Kario; Satoshi Hoshide; Koichi Yamamoto; Ayako Okura; Hiromi Rakugi
Journal:  J Hum Hypertens       Date:  2021-05-07       Impact factor: 3.012

Review 10.  An Update on Masked Hypertension.

Authors:  D Edmund Anstey; Daniel Pugliese; Marwah Abdalla; Natalie A Bello; Raymond Givens; Daichi Shimbo
Journal:  Curr Hypertens Rep       Date:  2017-10-25       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.